Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Crl
  6. /
  7. Belcher Pharmaceuticals, LLC
CRL
•Belcher Pharmaceuticals, LLC

Belcher Pharmaceuticals, LLC – FDA CRL

Record Details

The FDA issued a Complete Response Letter (CRL) to Belcher Pharmaceuticals, LLC. for its New Drug Application (NDA 207987) for Ablysinol (Dehydrated Alcohol Injection, USP), indicating the application could not be approved due to significant deficiencies. Major concerns centered on unresolved chemistry, manufacturing, and controls (CMC) issues, leading to a "withhold" recommendation for the drug substance manufacturing facility, which was also found "not ready for inspection." Specific product quality issues included inadequate drug product specifications, insufficient stability data due to unvalidated analytical methods, and deficiencies in microbiological testing validation. While clinical effectiveness was acknowledged, the application lacked adequate information on instructions for use, especially dosing, and expected adverse event rates. Regulatory actions required Belcher Pharmaceuticals to address all CMC deficiencies, ensure the manufacturing facility is ready for inspection, revise prescribing information to conform with 21 CFR 201.56 and 201.57, update carton and container labels, and provide a comprehensive safety update. Furthermore, the FDA anticipates requiring postmarketing studies under Section 505(o)(3) of the FDCA to analyze potential serious risks upon approval.

Company
Belcher Pharmaceuticals, LLC
Product type
Drugs
Person
  • Mihir Taneja
View Company Profile

ID · e04d8e92-7dd3-4727-8892-ce1eb036b77f

Other documents for Belcher Pharmaceuticals, LLC
  • 483 - 2024-08-16August 16, 2024
  • 483 - 2022-11-04November 4, 2022
  • 483 - 2021-11-15November 15, 2021
  • EIR - 2019-05-24May 24, 2019
  • EIR - 2016-05-13May 13, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Belcher Pharmaceuticals, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.